StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

NewcelX's total debt was $355.00K at Dec 31, 2025. For fiscal 2025 it was $355.00K, down 95.4% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$355.00K-95.4%
FY2024Dec 31, 2024$7.73M+5050.7%
FY2020Dec 31, 2020$150.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$355.00K–
Q4 FY2024Dec 31, 2024$7.73M–
Q3 FY2024Oct 10, 2024$2.79M–
Q4 FY2020Dec 31, 2020$150.00K–

More NewcelX figures

See a number that looks wrong?